Free Virtual Consultations. Corona Virus Related Cases Click Here.
ACCIDENT NEWS

1 Killed in Crash at 91 Freeway and Central Avenue


Car Rear-Ends Truck in Fatal Carson Accident

Carson, CA (March 22, 2020) – One person was killed in a crash in Carson. The fatal accident occurred on the evening of March 22 at Highway 91 and Central Avenue.

A vehicle rear-ended a truck in the westbound lanes of the 91 Freeway at Central Avenue. The vehicle became stuck underneath the truck. One person was killed in the crash.

Our heartfelt condolences go out to the friends and loved ones of the victim. 

#Carson

#90746


December 20, 2019

Man Injured in Crash on Interstate 5 Near Rowlee Road

Victim Hit by Semi Truck in Second Accident in Buttonwillow...


November 27, 2019

Man Killed in Pedestrian Crash at Goldenwest Street

Victim Hit by Car in Fatal Huntington Beach Accident ...


January 2, 2020

1 Killed, 5 Injured in Crash on 10 Freeway Near Holt Avenue

4 Vehicles Involved in Fatal Chain-Reaction Accident in West Covina...

Free Police Report Request

We offer free consultation. No office visit required, we will get back to you within 24 hours.

  • This field is for validation purposes and should be left unchanged.

What can we do for you?

  • Answer your legal question.
  • Provide a Free Case Evaluation.
  • Schedule an appointment.

Why Choose Us?

  • Available 24/7
  • Trusted Since 1990
  • Local to You
  • Recovered $350,000,000
  • 5 Star Reviews
  • Free Case Evaluation
  • VIP Service
  • No Win, No Fee

Latest Law Post


May 22, 2020

Johnson & Johnson Discontinues Talc-Based Baby Powder

baby powder new Johnson & Johnson discontinued its talc-based baby powders in the United States and Canada because thousands of lawsuits claiming it was contaminated with asbestos created a sales decline.


May 18, 2020

FDA Issues Warnings To Two Manufacturers Of Breast Implants

The U.S. Food and Drug Administration (FDA) just issued warning letters to two manufacturers of breast implants for failing to comply with regulatory requirements. The FDA sent a warning letter to Allergan for failure to comply with requirements to conduct post-approval studies assessing the risks and long-term safety of two separate breast implant models. Both breast implant models were voluntarily recalled last year. The FDA also sent a warning letter to Ideal Implant Incorporated. That letter was sent for failing to comply with adverse event reporting requirements and current good manufacturing practice requirements. The letter was prompted by an inspection which was conducted earlier in 2020.